Published: 21 August 2019
Author(s): Hajer Lejri-El Euchi, Emmanuel Chirpaz, Aurélie Foucher, Nathalie Sultan-Bichat, Andry Randrianjohany, Patrice Poubeau, Etienne Gamon, Céline Roussin, Sophie Osdoit, Loïc Raffray
Issue: August 2019
Section: Original Article

Patients under biological therapy for auto-immune disease are considered immunosuppressed and several recent recommendations highlight the need for vaccination against influenza and pneumococcal infections. The aims of this study were to evaluate influenza and pneumococcal vaccine coverage among patients receiving biological therapy and identify factors associated with vaccine uptake within this population.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.